and recommendation

StemCells, Inc. (STEM)
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimers disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
- June 2, 2018 - 7:11am | Out and About, Out and About, Earnings, Earnings Q1
- April 2, 2018 - 9:03am | Out and About, Out and About
- March 10, 2018 - 9:22am | Earnings, Earnings Q4
- February 26, 2018 - 12:52pm | Out and About
- February 6, 2018 - 2:55pm | Out and About
- January 30, 2018 - 7:59pm | Out and About, Research Notes
- January 1, 2018 - 11:12pm | Out and About
- November 14, 2017 - 6:20pm | Research Notes
- November 3, 2017 - 1:08pm | Earnings, Earnings Q3
- May 5, 2017 - 8:59am | Earnings, Earnings Q1
- May 3, 2017 - 11:00am | Out and About, Research Notes
- March 27, 2017 - 12:52pm | Out and About, Research Notes
- March 10, 2017 - 12:00am | Earnings, Earnings Q4
- February 9, 2017 - 1:13pm | Research Notes
- February 8, 2017 - 12:41pm | Research Notes
- February 7, 2017 - 12:42pm | Research Notes
- January 26, 2017 - 1:12pm | Research Notes
- January 24, 2017 - 1:07pm | Research Notes
- January 18, 2017 - 4:36pm | Research Notes, Financings
- January 5, 2017 - 10:16am | Research Notes